Counterpoint Mutual Funds’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,775
Closed -$295K 350
2025
Q4
$295K Buy
+2,775
New +$322K 0.02% 269
2025
Q3
Sell
-15,523
Closed -$1.9M 375
2025
Q2
$1.9M Buy
+15,523
New +$1.77M 0.17% 49
2025
Q1
Sell
-4,187
Closed -$387K 326
2024
Q4
$387K Buy
4,187
+1,458
+53% +$143K 0.05% 162
2024
Q3
$264K Buy
+2,729
New +$245K 0.05% 174
2023
Q2
Sell
-2,092
Closed -$113K 354
2023
Q1
$113K Sell
2,092
-249
-11% -$14.5K 0.1% 96
2022
Q4
$140K Buy
+2,341
New +$127K 0.15% 157

Other funds holding EHC

Counterpoint Mutual Funds's EHC Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 2,775 shares — an estimated $295K sold.

Counterpoint Mutual Funds first reported a position in EHC in Q4 2022 and held it in 6 quarters. The position peaked at $1.9M in Q2 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Counterpoint Mutual Funds reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 2,775 Encompass Health shares in Q1 2026, an estimated $295K.
  • Counterpoint Mutual Funds first reported a position in Encompass Health in Q4 2022 and held it in 6 quarters.
  • Counterpoint Mutual Funds's Encompass Health position peaked at $1.9M in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.